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Control and elimination of the parasitic disease schistosomiasis relies on mass administration
of praziquantel. Whilst these programmes reduce infection prevalence and intensity, their
impact on parasite transmission and evolution is poorly understood. Here we examine the
genomic impact of repeated mass drug administration on Schistosoma mansoni populations
with documented reduced praziquantel efficacy. We sequenced whole-genomes of 198 S.
mansoni larvae from 34 Ugandan children from regions with contrasting praziquantel expo-
sure. Parasites infecting children from Lake Victoria, a transmission hotspot, form a diverse
panmictic population. A single round of treatment did not reduce this diversity with no
apparent population contraction caused by long-term praziquantel use. We find evidence of
positive selection acting on members of gene families previously implicated in praziquantel
action, but detect no high frequency functionally impactful variants. As efforts to eliminate
schistosomiasis intensify, our study provides a foundation for genomic surveillance of this
major human parasite.
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Schistosomiasis is one of the most important neglected tro-pical diseases (NTDs), currently infecting over 240 millionpeople across 78 countries, primarily in sub-Saharan
Africa1. In 2001 the World Health Organization (WHO)
endorsed preventive chemotherapy, in the form of mass drug
administration (MDA) of praziquantel, as the primary strategy
for schistosomiasis control2. Praziquantel MDA aims to provide
periodic, typically annual, treatment of large populations at risk
of disease, focusing primarily on school-aged children, a group
shown to have the highest infection prevalence, intensity and
future morbidity risks3,4. MDA in sub-Saharan Africa com-
menced in 2003, starting in Uganda, and in 2019 alone, MDA
programmes delivered praziquantel to 105.4 million people5.
These programmes have, in general, been effective at reducing
the prevalence and intensities of infections in targeted regions6–8.
Following these early successes, in 2012, the WHO set goals of
controlling schistosomiasis morbidity (defined as reducing the
prevalence of heavy intensity infections to <5% across sentinel
sites) by 2020, eliminating schistosomiasis as a public health
problem (EPHP, defined as reduced the prevalence of high-
intensity infections to <1% across all sentinel sites) by 2025 and in
selected regions, complete interruption of transmission, by
20258,9. Most recently, the revised WHO 2021–2030 NTD
roadmap was launched, with its more ambitious goal to achieve
EPHP in all 78 endemic countries, and interruption of trans-
mission in selected regions, by 203010.
However, despite the many successes to date, numerous per-
sistent schistosomiasis hotspots remain8,11–14. The precise rea-
sons for which are largely unknown but they present substantial
challenges toward reaching these ambitious 2030 targets. Accu-
rately measuring changes in parasite populations will be a key
part of understanding the current and future impact of MDA15,16.
Populations of S. mansoni appear, in general, to be structured at
national or continental scales, with several million nucleotide
variants differentiating populations in East and West Africa17,18.
However, population genetic studies at smaller scales have
reported panmictic populations with high within-host
variability19–21. Estimation of key population parameters such
as genetic diversity, population structure and parasite relatedness
can all be used to infer recent demographic changes and the
efficacy of interventions. While a number of population genetic
studies have assessed how Schistosoma spp. populations have
changed following MDA22–24, these have been restricted to a
limited number of molecular markers. By contrast, few studies
have analysed whole-genome or exome sequence data from
populations of S. mansoni17,25 or other schistosomes17,25–27.
These genomic approaches have the capacity to resolve parasite
population structure, detect localised signatures of positive
selection and inform epidemiological models of schistosomiasis28.
For example, a reduction in the genetic diversity of a population
might suggest the occurrence of a population bottleneck followed
by inbreeding and the accumulation of deleterious alleles, which
could be indicative of a population close to elimination29. Evi-
dence of localised selection in the genome or the emergence and
rapid rise in frequency of novel genotypes—particularly in the
absence of a bottleneck, could indicate that a population is rapidly
evolving in response to control measures.
The degree to which parasite population structure is influenced
by current control measures is unknown, but adaptation is a
particular concern. MDA programmes are highly dependent on
the continued efficacy of praziquantel, the only drug available for
widespread use that is effective against all human-infective
schistosome species30–32. Drug resistance is an increasingly
common consequence of large-scale treatment regimes and has
emerged in veterinary systems to all major classes of
anthelmintics33–35. Whilst there is no consensus as to its precise
genetic basis, resistance to praziquantel can be experimentally
induced in laboratory populations of S. mansoni36–39. Further-
more, several studies have reported potential reduced anthel-
mintic efficacy in endemic regions40–42, although suggestions of
widespread praziquantel resistance remain controversial43–47. In
programmes that target only school-age children or other subsets
of the population, there will be large refugia from drug
selection48. However, with the proposed expansion of human
MDA programmes to wider community-level coverage, prazi-
quantel use is expected to exert increasing selective pressure for
reduced praziquantel susceptibility. Surveillance for reduced
praziquantel efficacy amongst MDA programmes currently relies
only on slide-based egg counts before and after treatment to
estimate egg reduction rates (ERR); the proportional reduction in
egg output following treatment49–51. Genome-wide approaches
have, in contrast, the potential to detect and monitor markers to
track the spread of resistance through natural populations16.
At the beginning of the first national MDA programme in
Uganda in 2003, a 2-year school-based longitudinal survey in a
high transmission region found evidence of natural praziquantel
tolerance in these S. mansoni populations20. A survey involving
the same schools in 2014 found that the ERR was significantly
lower in parasites from children in schools that had received 8–9
rounds of annual MDA compared with schools that had received
1–5 previous rounds42. Together these studies suggested that the
selective pressure of repeated MDA has acted on pre-existing
genetic variation in praziquantel susceptibility resulting in
reduced praziquantel efficacy.
In order to elucidate the genomic impact of long-term MDA
and gain insights into the genomic diversity and potential gene
flow amongst natural S. mansoni populations, we performed
whole-genome sequencing on parasites collected during the
2014 survey42. We sequenced individual miracidia from children
attending primary school in regions of either long-term MDA
pressure (8–9 previous annual rounds) or short-term MDA
pressure (1 previous round) from two Ugandan districts ~100 km
apart. These children exhibited a range of parasite clearance
phenotypes following praziquantel treatment, of which low
clearance is potentially indicative of praziquantel-resistant
parasites42. Using these data we report the genetic structure of
S. mansoni across these two districts and determine whether there
are observable recent changes in schistosome diversity that could
be attributed to repeated praziquantel treatment. Based on data
from pre- and post-treatment samples and the treatment
response of individual children we investigated whether a single
round of praziquantel treatment could reduce host infrapopula-
tion diversity. Finally, we looked for evidence of recent selection
which might explain the apparently reduced praziquantel efficacy
in regions of long-term MDA and whether any variants are
strongly associated with drug response. This study represents the
largest whole-genome sequencing study, and the first whole-
genome analysis of the effect of drug treatment, on schistosome
populations from endemic regions.
Results
Whole-genome sequencing of individual miracidia. We selected
222 larval schistosomes (miracidia) sampled in 2014 from chil-
dren attending four primary schools in Eastern Uganda (Table 1,
Fig. 1)42 for whole-genome sequencing. The majority of miracidia
were from Mayuge district (n= 181; from 31 children), where
MDA had occurred annually in primary schools since 2003 (with
the exception of 2008–2009). All three of the study sites in
Mayuge (Bugoto, Bwondha and Musubi schools) were within
0.5 km of the shore of Lake Victoria. The remaining miracidia
were sampled from Kocoge school (n= 17; from 3 children),
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located in Tororo district, which is close to the Kenyan border
and ~100 km from Mayuge district. MDA commenced in Tororo
district from 2013, indicating one previous round of treatment
prior to our sampling. We also included S. mansoni sequence data
from Crellen et al.17 of adult worms isolated from Senegal,
Cameroon, Kenya, Puerto Rico, Guadeloupe (3 samples) and two
samples from Uganda from Walukuba school (Lake Albert) and
Buloosi school (Lake Victoria). Alignment of miracidia sequence
reads to the S. mansoni genome revealed high per-sample map-
ping rates (median 88.78% of reads mapped with mapping quality
MQ >40; Supplementary Data 1). Reads mapped to the majority
of the genome (median of 97.83% of bases covered across all
samples), although the median read depth was highly variable
across samples (0.13–58x) and substantially lower over the Z-
specific region of the Z chromosome due to the inclusion of both
male (ZZ) and female (ZW) miracidia in our sample set (Sup-
plementary Data 1, Supplementary Fig. 1). Across all 207 samples,
we produced a high-quality variant dataset (Supplementary
Fig. 2) comprising 6,268,157 single-nucleotide polymorphisms
(SNPs) and 442,787 indels (including mixed SNP/indel variant
sites) from 198 miracidia and 9 adult worms.
Population structure of Ugandan Schistosoma mansoni. We
characterised the population structure at different spatial scales
using a subset of 1,344,965 autosomal variants, filtered to remove
variants in strong linkage disequilibrium. Principal component
analysis revealed separation of S. mansoni parasites by country
along the first principal component and separation of the
Ugandan samples by proximity to Lake Victoria along the second
principal component (Fig. 2a). While the first four principal
components explained 60% of the total variance, they did not
differentiate parasite populations within Mayuge district by
school or infrapopulation (Fig. 2a and b, Supplementary Figs. 3
and 4). Phylogenetic analysis showed that parasites from outside
Uganda and the parasites from Tororo district formed distinct
clades but there was no discernable structure within parasites
from Mayuge district (Fig. 2c). ADMIXTURE analysis also con-
sistently differentiated parasites of Tororo district from those of
Mayuge, although cross-validation analysis (Supplementary
Fig. 5) could not identify the most likely number of subpopula-
tions (K), we confirmed this for a range of K values (Fig. 2f).
Effective population size (Ne) showed broadly consistent popu-
lation histories across all schools (Supplementary Figs. 6 and 7).
Estimates of Ne over time plateau ~10,000 years ago and were
consistent between the Lake Victoria schools (3.30–3.69 × 104)
and slightly reduced in Kocoge school (2.61 × 104).
Genome-wide estimates of median nucleotide diversity within
parasite populations were consistent across all schools (πBugoto,
πBwondha, πMusubi= 0.0033, πKocoge= 0.0032; Fig. 2d). Estimates of
relative (FST) and absolute (dXY) differentiation showed low levels
of differentiation but slightly elevated values between parasites
sampled from schools in different districts (range dXY= 0.0034,
range FST= 0.0233–0.0247), compared with those sampled within
the same district (range dXY= 0.0033, range FST= 0; Fig. 2e).
Analysis of parasite populations within individual children
showed approximately equivalent levels of nucleotide diversity
(range π= 0.0027–0.0036) to the range found within schools
(Supplementary Fig. 8a). Differentiation between infrapopulations
was generally low, both between schools (range FST= 0–0.0339,
range dXY= 0.0032–0.0038; Supplementary Data 2) and within
schools (range FST= 0–0.0123, range dXY= 0.0032–0.0037; Sup-
plementary Data 2). There was no significant difference in
nucleotide diversity between infrapopulations from male or female
schoolchildren (p= 0.2249, Supplementary Fig. 8b). Likewise,
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and child age (R2= 0.051, p= 0.2, Supplementary Fig. 8c),
infrapopulation size (R2= 0.0099, p= 0.57, Supplementary
Fig. 8d). Pairwise comparisons also revealed no evidence of first,
second or third order kinship relationships between any miracidia.
Analysis of differential coverage between pseudoautosomal and Z-
specific regions of the S. mansoni Z chromosome identified 103
miracidia samples as female and 95 as male (Supplementary Fig. 9,
Supplementary Data 3).
Population size changes in regions of long-term MDA. We
examined genome-wide allele frequency patterns to determine
whether there was any evidence of a recent reduction in popu-
lation size. Evidence of a recent population bottleneck could
indicate that school-based MDA coverage has been sufficiently
high to impact S. mansoni populations in Mayuge district despite
the refugia in untreated hosts, such as adults, pre-school-aged
children, non-school-attending children and snail vectors. Ana-
lysis of the one-dimensional site frequency spectra (1D-SFS) for
each school population showed an abundance of rare (singleton
and doubleton) alleles, suggestive of a large or growing popula-
tion (Fig. 3a, Supplementary Fig. 10)52. Genome-wide Tajima’s D
estimates were negative in all populations suggesting an excess of
low-frequency polymorphisms compared to expectations (Fig. 3b,
Supplementary Fig. 11). A negative Tajima’s D is consistent with
a population expansion after a selective sweep although genome-
wide Tajima’s D and 1D-SFS results are broadly consistent
between the two districts, so it is unlikely this is due to MDA53.
Evidence of positive selection in regions of long-term MDA.
Based on the differences in past treatment history with
praziquantel and genomic evidence of geographical separation
between populations, we screened for evidence of recent selection
within Mayuge district and between Mayuge and Tororo districts
using a number of genome-wide methods. Multiple regions were
identified by the integrated haplotype score (iHS) test as being
under strong selection in Mayuge where we expect selection for
survival following praziquantel treatment to be strongest (Fig. 4a).
Several of these regions also showed high genetic differentiation or
differences in haplotype frequencies between populations from
Mayuge and Tororo District using the fixation index (FST) and
cross-population extended haplotype homozygosity (XP-EHH)
statistics, respectively (Fig. 4c and d). We also determined whether
any of these selected regions intersected with regions of reduced
genetic diversity in the Mayuge samples (compared to Tororo)
which could indicate targeted selection on a locus (Fig. 4e).
Overall, we identified 25 non-redundant regions (range= 0.010–
1.37Mb, total length= 7.86Mb) with extreme iHS, FST or XP-EHH
scores (Fig. 4, Supplementary Data 4 and 5) encompassing 183 genes
(representing 1.80% of all coding genes), of which 176 contained at
least one variant in one or more samples (Supplementary Data 6, 7).
The strongest signals of selection were detected within
chromosome 2. Our tests found evidence of geographically
localised selection with extreme iHS values in seven regions of
this chromosome (total length 2.69 Mb; Fig. 3a). Two of these
regions overlapped with elevated XP-EHH, FST values and
reduced relative nucleotide diversity (Fig. 3c–e, Supplementary
Fig. 12, Supplementary Data 4). Within one of these regions we
identified a single locus (47.06–47.34Mb) containing four
sodium/potassium/calcium exchanger proteins (Smp_170450,
Smp_336070, Smp_328710, Smp_094390; Supplementary Fig. 13,
Supplementary Data 6). Broad families of calcium ion transpor-
ters, including voltage-operated Ca2+ channels, have been
suggested as a means of praziquantel mediated calcium
uptake54–57 with changes in these channels being suggested as
potential means of resistance58,59. Of these four genes, three
contained variants corresponding to predicted missense, non-
sense and splicing variants (7 in Smp_094390, 19 in Smp_170450
and 1 in Smp_336070). All the non-synonymous variants were
found in Smp_170450 and had a MAF>10% within the Mayuge
parasite population (Supplementary Data 7).
Several other candidate regions were identified including a
region of extreme iHS scores in the Mayuge population at the
start of chromosome 4 that encompassed 11 genes (Supplemen-
tary Fig. 14). This region included a gene predicted to encode an
ATP-binding cassette (ABC) transporter smdr1 (Smp_063000)
although the entire region had elevated relative nucleotide
diversity compared to Tororo and iHS scores were higher in
Tororo samples compared to Mayuge samples across the 56 kb
span of this gene.
Further evidence of positive selection was found at the start of
chromosome 2 (3.55–4.81 Mb, Supplementary Fig. 15). We also
found comparatively lower nucleotide diversity in this region
within the Mayuge populations compared to the Tororo
population. This region encompassed 19 genes all of which
contained one or more variants but no clear candidates for
praziquantel-linked selection were identified. Similar results were
found when other candidate regions were examined (Supple-
mentary Figs. 16 and 17). We also found no obvious evidence of
selection acting on the Ca2+-permeable transient receptor
potential (TRP) channel (Smp_246790) recently identified as a
likely target of praziquantel activity and possible means of
praziquantel resistance (Supplementary Fig. 18)60–62.
Short-term impact of treatment on genomic diversity. We
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Fig. 1 Study design and summary of miracidia stage samples sequenced.
a Sampling was performed in two districts in Uganda; Mayuge district and
Tororo district. Within those regions four schools were selected, three from
Mayuge district which borders Lake Victoria: Bwondha (green), Bugoto
(light blue) and Musubi (yellow). One school from the Tororo district, close
to the Kenya border, was chosen: Kocoge (pink). Mayuge district and
Tororo district primary schools in each region have been under long-term
and short-term mass drug administration (MDA) pressure, respectively.
b Pre- and post-treatment sampling information. Circles indicate the
numbers of miracidia sampled at week 0 (immediately before treatment)
and 4 weeks post-treatment, lines indicate miracidia sampled at both time
points from the same children, only samples passing read sequence quality
control are included.
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Fig. 2 Schistosoma mansoni population structure. Principal component analysis (PCA) of genetic differentiation within and between the 198 S. mansoni
isolates produced in the present study, plus nine previously published samples from Uganda and elsewhere. a Principal components 1 and 2 and
b components 3 and 4 with the first four principal components accounting for 60% of the total variance. Points represent samples from three schools
Mayuge district (Uganda), Bugoto (light blue), Bwonda (green) and Musubi (yellow) and one school from Tororo district, Kocoge (pink). We included nine
additional previously published samples, one sample was from Buloosi school (orange) ~40 km east of Mayuge district, a second sample was from
Walukuba school (dark blue) near Lake Albert and the remaining samples (grey) were from Guadeloupe, Senegal, Kenya, Puerto Rico and Cameroon.
c Midpoint rooted neighbour-joining phylogeny showing the relatedness between samples, branches are coloured based on the school or region where
sample collection occurred. d Autosomal nucleotide diversity (π) values, calculated as the mean of non-overlapping 5 kb windows for each school
population: Bugoto (n= 75 miracidia), Bwondha (n= 60), Musubi (n= 46) and Kocoge (n= 17). For all boxplots, the central line indicates the median, the
top and bottom edges of the box indicate the 25th and 75th percentiles, respectively. The maximum whisker lengths are specified as 1.5 times the
interquartile range. e Pairwise comparisons of fixation index (FST) and absolute divergence (dXY) between each school population. Both statistics were
calculated using autosomal variants in non-overlapping 5 kb windows using the same sample sizes as (d). Median values for each comparison are shown in
bold, numbers in parentheses represent the 95% bootstrap confidence intervals around the median. f ADMIXTURE plots illustrating the population
structure, assuming 2–4 populations are present (K), using 10-fold cross-validation and standard error estimation with 250 bootstraps. Y-axis values show
admixture proportions for different values of K (K= 2–4), each shade of purple indicates a different population.
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sampling, forming three groups (Fig. 5). Samples from children with
no miracidial hatching after treatment were classified as ‘good
clearers’, samples from children with post-treatment miracidial
hatching were grouped as either ‘pre-treatment’ if they were sampled
prior to treatment or ‘post-treatment’ if they were sampled four
weeks post-treatment. We excluded all 17 samples from Tororo
district (Kocoge school) as all of these samples were derived from
children with ‘good’ clearance phenotypes. Both pre- and post-
treatment populations had slightly lower levels of nucleotide diver-
sity (median πPre-treatment= 0.0030, median πPost-treatment= 0.0030)
compared to parasite populations from children with good clearance
phenotypes (median πGood clearers= 0.0032; Fig. 5a). Estimates of
relative (FST) and absolute (dXY) differentiation between these three
populations showed minimal variation between any populations for
both metrics (Fig. 5b), and in particular, showed no difference in
allele frequencies between pre- and post-treatment samples from
poor clearance individuals. Pairwise genome-wide FST analysis did
not highlight any regions of elevated values between any of the three
populations (Fig. 5c).
Genome-wide association for parasite clearance. Given the
importance of understanding the genetic mechanism of prazi-
quantel resistance, we also formally tested for an association
between reduced clearance phenotypes and autosomal S. mansoni
variants. We conducted this analysis despite the limited sample
size and number of children with poor clearance phenotypes
(Table 1). First, we performed a binary trait association between
miracidia sampled from children with good clearance phenotypes
(where treatment appeared to be highly effective) and miracidia
isolated post-treatment from children with poor clearance phe-
notypes (where miracidia are potentially derived from parasites
that survived treatment; Fig. 5d). Second, we performed quanti-
tative trait genome-wide association analysis using estimated ERR
as the phenotype (Fig. 5e). The binary association test found no
variants significantly associated with a poor clearance phenotype.
The quantitative trait association test only identified four widely
distributed variants associated with lower estimated ERR (Fig. 5e,
Supplementary Data 8) and none were predicted to alter protein
sequences (2 were intergenic SNPs, 1 SNP was found in a 3′ UTR
and the other variant was an intronic indel).
Discussion
The newly launched WHO NTD roadmap has set clear goals for
the control and elimination of schistosomiasis and states that this
will require extending mass treatment to all endemic populations
and age groups10. Meeting these goals will require a greater
understanding of how current and future interventions impact
schistosome populations. This includes population change in
response to repeated MDA as well as monitoring for the potential
emergence and spread of praziquantel resistance. We therefore
performed whole-genome sequencing of individual S. mansoni
miracidia collected from epidemiologically important, high pre-
valence settings42. We sampled parasites from two districts in
Uganda with different histories of praziquantel MDA and cor-
responding reduced efficacy of praziquantel in schools with a
higher exposure to MDA42.
Our analyses, which included adult worms from multiple
countries, revealed clear population structure over national and
continental scales. Within Uganda, we could distinguish parasites
from Lake Albert and Lake Victoria, ~350–450 km apart, as well
as miracidial populations sampled from two districts in Eastern
Uganda, ~100 km apart. Parasites collected from children in three
schools bordering Lake Victoria formed a panmictic and highly
diverse population, with equivalent levels of diversity found
within populations sampled from individual children as from
across the district. This is consistent with population genetic
surveys that have found high genetic diversity but minimal
population structure among schistosomes sampled from different
shoreline regions around Lake Victoria18–20,22,63,64. We found no
indication that this genomic diversity was correlated with host-
specific factors, despite some prior population genetic studies
suggesting variance by host age or sex20,65–70. Consistent with the
limited number of miracidia sampled relative to the high within-
host diversity, we found no related miracidia (up to 3rd degree).
Estimates by Aemero et al.71 found that the majority (66–92%) of
adult worm pairs from hosts are unrelated although sibship
reconstruction models have shown that accurate estimations of
relatedness depend on the number of sampled parasites72.
Parasite genetic diversity is thought to be influenced by a range
of epidemiological and host-specific factors73. At the intermediate
host level, individual snails are typically found to support and
shed a limited number of parasite genotypes74 and have short
lifespans. However, a high proportion of adults in these shoreline
communities work in the fishing industry which leads to families
moving around the Lake, and possibly crossing national borders,
to increase their fishing yield75. This mobility leads to individuals
being exposed to, and infecting, different snail populations
around the lake shores and so facilitates gene flow and high
within-host diversity.
This large population and high level of diversity would be
expected to provide a strong adaptive advantage to S. mansoni
populations allowing praziquantel resistance to develop more
rapidly compared to less diverse populations76,77. At the district









































Fig. 3 Genome-wide allele frequency patterns. a One-dimensional site
frequency spectra for each parasite population sampled from children in
each school: Bugoto (light blue), Bwondha (green), Musubi (yellow) and
Kocoge (pink). For each school, miracidial populations were subsampled
(n= 15 miracidia per school) and site frequency spectra were calculated,
this was repeated for a total of five replicates. The x-axis represents the
derived allele frequency and y-axis represents the proportion of sites at
each allele frequency. Coloured bars represent the median proportion of
sites across all replicates for each school, black error bars represent the
standard deviation around the median for all replicates, grey points
represent the individual results for each replicate. b Median Tajima’s D
values calculated in 5 kb windows across each autosome for each school
population. For all boxplots, the central line indicates the median, the top
and bottom edges of the box indicate the 25th and 75th percentiles,
respectively. The maximum whisker lengths are specified as 1.5 times the
interquartile range.
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of rare alleles in both Mayuge and Tororo populations. This could
indicate a recent population bottleneck, followed by a population
expansion, but it is unclear whether this is due to MDA. The
negative Tajima’s D signal is similar in both Mayuge and Tororo
populations, and is present genome-wide suggesting that it is not
due to a selective sweep at one or a few individual loci. At the
infrapopulation level, comparison of pre- and post-treatment
populations showed that praziquantel did not substantially reduce
genomic diversity over a single round of treatment. We found
minimal genomic differentiation between these populations sug-
gesting post-treatment populations do not represent a distinct
subpopulation. Across multiple studies, praziquantel treatment
appears to have a variable impact on population genetic diversity
with either no impact23,24,67,78,79 or a reduction in diversity
which recovered within months of treatment20,22,80. To our
knowledge, no studies have shown long-term reductions in
Fig. 4 Signatures of recent selection. a Genome-wide integrated haplotype scores (iHS) within the Mayuge population (n= 181) a region of long-term
MDA pressure (8–9 previous annual rounds). b Genome-wide integrated haplotype scores (iHS) within the Tororo populations (n= 17), a region of short-
term MDA pressure (1 previous round with limited coverage). Points represent median values of all variants in 2 kb non-overlapping windows along the
eight S. mansoni chromosomes (shown in alternating shades of grey). c Genome-wide cross-population extended haplotype heterozygosity values (XP-
EHH) between populations from Mayuge district and Tororo district, calculated as the median of all variants in 2 kb non-overlapping windows. d Fixation
index (FST) values between populations from Mayuge district and Tororo district, calculated as the mean of FST scores in non-overlapping 2 kb windows.
e Nucleotide diversity was calculated as the mean of 2 kb windows across each chromosome for each district, the ratio between Mayuge and Tororo 2 kb
windows is shown. Windows with the highest 0.25% of values in the Mayuge iHS, FST and XP-EHH statistics (shown as red points) were used to define
candidate regions of selection. Windows with a 300 kb of each other were joined into continuous regions of selection, any of those regions with <8
windows with elevated values across any statistic were discarded (Supplementary Data 4).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24958-0 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:4776 | https://doi.org/10.1038/s41467-021-24958-0 |www.nature.com/naturecommunications 7
population genetic diversity in high prevalence settings. Van den
Broeck et al.81 recently modelled the potential impact of repeated
praziquantel administration on schistosome populations. Their
simulations suggested that repeated treatment could result in a
measurable decline in genetic diversity at 95% treatment cover-
age. However, lasting declines were only predicted at 100%
treatment coverage sustained over a minimum of six treatment
rounds, a level of coverage that has not been attained in any
endemic region.
Given the reduced praziquantel efficacy observed by Crellen
et al.42, we scanned the genomes for evidence of recent selection
within Mayuge district, which could indicate adaptation to long-
term MDA pressure. Evidence of positive selection was found in
25 regions of the S. mansoni genome, encompassing several genes
from gene families suggested as potential mediators of prazi-
quantel action or resistance. This included a gene encoding an
ABC transporter that could represent a potential means of pra-
ziquantel efflux82–85, and multiple calcium ion transporters that
could regulate calcium influx caused by praziquantel54–59. How-
ever, many of these candidate genes were not found directly
under the peak of these signals of positive selection and most
functionally impactful variants were found at low frequencies
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within the Mayuge populations. Notably, we also found no evi-
dence of selection acting on the Ca2+-permeable transient
receptor potential (TRP) channel (Smp_246790) recently identi-
fied as a likely target of praziquantel activity60–62.
The simplest model of how selection leads to anthelmintic
resistance would be for an initially rare resistance mutation at a
single locus to be swept to fixation in a population (i.e. a hard
selective sweep). Such events leave a strong signature in the
genome around the locus, which can be detected by a number of
population genetic methods, such as FST and the haplotype tests
that we employed in this study. Other scenarios, such as the
presence of a resistance allele across a range of genetic back-
grounds, which subsequently rise to higher frequencies (i.e. a soft
sweep)86, or polygenic traits are more difficult to detect and may
have been missed by our study. This type of soft sweep is more
likely to occur in a large and diverse population such as S.
mansoni around Lake Victoria and has been observed under
similar scenarios in other helminth species87–89. If variants for
praziquantel resistance are present across a range of genetic
backgrounds, this could explain why genetic variation has been
maintained over 10 years of MDA. Similarly, if praziquantel
resistance is a polygenic trait with many mutations driving
resistance, either additively or synergistically, the methods used in
this study may be unable to detect such genes.
As MDA is not synchronised between the adjoining countries
around Lake Victoria, these communities can miss praziquantel
treatment rounds90,91 and likely act as refugia of diverse parasites
supporting the panmictic population structure. The high rates of
gene flow we observed around Lake Victoria coupled with this
diversity could also be preventing selection for or fixation of
resistance-conferring variants. Even over the course of 8–9 years
of MDA, post-treatment populations are small relative to the
refugia populations in snails and untreated humans (adults,
lightly infected individuals and asymptomatic carriers), and the
high rates of gene flow between populations allow for rapid
recovery of genetic diversity following treatment48,92. The long-
evity of adult schistosomes is likely to increase the effectiveness of
these reservoirs of genetic diversity; even small numbers of sen-
sitive adults surviving in refugia will produce eggs for many years.
Management strategies for veterinary helminth infections often
aim to create refugia populations to reduce the selection pressure
for resistance48,93,94 and it appears that the limited community
coverage of MDA programmes may have had a similar effect. It is
still possible that in the short-term, the long lifespan of adult
schistosomes might enable praziquantel-resistant parasites to
survive the entire duration of a school child’s MDA, allowing
them to act as a reservoir of resistance alleles95,96. However, over
longer timescales, at present levels of MDA coverage, any
resistance-conferring variants are unlikely to be stably maintained
in these populations, especially if they exhibit the reduced fitness
found in some praziquantel-resistant S. mansoni strains in the
laboratory97,98.
Praziquantel use also only represents a single selective pressure on
Mayuge S. mansoni populations. For example, inland and lakeshore
Biomphalaria are distinct populations and multiple Biomphalaria
species in Uganda can act as intermediate hosts for S. mansoni
cercariae (B. sudanica, B. pfeifferi, B. choanomphala)99–101. This
structure has been found to influence infection prevalence in
humans and could represent a differential selective pressure between
districts102. Furthermore, while we found no indication of popula-
tion structure by age or sex we do not know to what extent other
host factors may be further stratifying our sample populations.
Given the importance of identifying any evidence of reduced pra-
ziquantel susceptibility, we have focused our analyses on this but it is
highly likely that S. mansoni populations are responding and
adapting to a diverse range of selective pressures.
Our findings have broad implications for future control efforts
for schistosomiasis. As expected, our results show that MDA
targeting school-age children has had a limited impact on the
parasite population size or diversity at the community level. Our
finding that the population of S. mansoni in Mayuge remains
essentially panmictic is in contrast to Schistosoma japonicum
populations in China, where one sign that elimination efforts
have drastically reduced parasite circulation is the high level of
population structure and relatedness between parasites from
different hosts27,103. Together, these results suggest we are a long
way from dramatically reducing schistosome transmission in this
area of high infection prevalence and intensity. Mayuge district
had received 8 or 9 rounds of treatment at the time our samples
were collected, so this supports the growing consensus among the
schistosomiasis control community that targeted MDA alone will
be insufficient to interrupt schistosomiasis transmission10. We do
not identify a single, strong signature of selection for praziquantel
resistance, despite some evidence of reduced efficacy for the drug
in this district. It could be that low efficacy is not a sign of
resistance, but due to host or other factors47,104–106, but it is also
possible that multiple resistance-conferring alleles are present in
the population—as appears to be the case for oxamniquine
resistance25. If this is the case, we would expect resistance to
emerge rapidly as the planned expansion and intensification of
MDA coverage decreases the size of refugia, and therefore reduces
gene flow that would dilute resistance-conferring alleles.
To conclude, we found that schistosome populations remain
diverse and unstructured after nearly a decade of annual MDA and,
at present, there appears to be no indication of a praziquantel-
resistant subpopulation driving reduced clearance parasite
Fig. 5 The impact of a single round of praziquantel treatment on Mayuge district Schistosoma mansoni populations. Populations were stratified into
three groups based on clearance phenotype and time of sampling. Samples from children with no miracidial hatching after treatment were classified as
‘good clearers’ (n= 81, purple), samples from children with post-treatment miracidial hatching were grouped as either ‘pre-treatment’ (n= 67, pink) or
‘post-treatment’ (n= 57, orange) if they were sampled 25–27 days post-treatment. a Nucleotide diversity (π) estimates calculated in 5 kb, non-overlapping
windows across each autosome for each population. For all boxplots, the central line indicates the median, the top and bottom edges of the box indicate the
25th and 75th percentiles, respectively. The maximum whisker lengths are specified as 1.5 times the interquartile range. b Pairwise comparisons of the
fixation index (FST) and absolute divergence (dXY) between populations, calculated in 5 kb, non-overlapping windows across all autosomes for each
population. Numbers in bold represent the median value of all windows, numbers in parentheses represent the 95% bootstrap confidence intervals around
the median. c Pairwise FST estimates between each population, plotted as median values in 2 kb windows along each autosome (shown in alternating
shades of grey). d Manhattan plot of significance values from logistic regression genome-wide association test, comparing populations sampled from good
clearers to miracidia only from post-treatment collections. The test was performed using the 281,350 autosomal variants found not to be in strong linkage
disequilibrium in these populations. eManhattan plot of significance values from linear regression genome-wide association test using the quantitative egg
reduction rate (ERR) estimates across all 181 Mayuge samples using the 281,954 autosomal variants not found to be in strong linkage disequilibrium. The
first four principal components of the PCA (Fig. 4) were used as covariates. The dashed lines represent the Bonferroni corrected significance threshold,
points higher than this threshold are shown in red.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24958-0 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:4776 | https://doi.org/10.1038/s41467-021-24958-0 |www.nature.com/naturecommunications 9
phenotypes. We did, however, identify a number of genomic regions
with strong signals of selection that could indicate gradual adapta-
tion to long-term praziquantel exposure or other selection pressures.
Given the limited understanding of how natural populations of S.
mansoni adapt to and are shaped by long-term MDA programmes
we recommend further genomic surveillance across endemic
regions. This surveillance would provide insights into the efficacy of
current control strategies and allow the impact of selection on the
parasite genome to be monitored providing advance warning of the
emergence of anthelmintic resistance. Our study represents the
largest WGS analysis of schistosome populations to date, and serves
as a template for future work.
Methods
Sample collection and ethical approval. Sampling was performed in Uganda,
which was the first country in sub-Saharan Africa to start MDA against
schistosomiasis42,107. This study was undertaken as part of monitoring and eva-
luation research activities conducted by the Schistosomiasis Control Initiative,
Imperial College London and the Vector Control Division of the Ministry of
Health, Uganda inherent with ongoing national disease control programme
activities. All methods were approved by the Uganda National Council for Science
and Technology (Memorandum of Understanding: sections 1.4, 1.5, 1.6) and the
Imperial College Research Ethics Committee (EC NO: 03.36. R&D No: 03/SB/
033E). This included the collection and publication of the indirect identifiers in
Supplementary Data 9. Within Uganda, districts, sub-counties and schools were
contacted about the nature of the fieldwork by the Head of the Vector Control
Division, Ministry of Health Uganda. The head-teacher of the school was informed
fully about the study and requested to provide informed consent, allowing the field-
teams to collect samples from children within the school. Parents of children at the
school were informed of the study through school meetings and were requested to
provide informed consent for their children to participate within the study. Prior to
consent, they were provided with detailed information as to why the study is taking
place and any questions were answered by the authors and technical staff that were
providing the information for the meeting. In addition to this, any child included
who had reached age 10, was also asked to sign and give informed consent after
receiving full information of the study. From those children from which their
parents have provided informed consent, random selection was undertaken by the
field-teams. Participation was voluntary, and children could withdraw or be
withdrawn from the study at any time. Access to treatment was not dependent on
consenting to participate in the study. All infected children were provided with
praziquantel at 40 mg kg−1.
We selected miracidia collected from children from four schools: three schools
in Mayuge district that borders Lake Victoria—Bugoto (n= 12 children), Bwondha
(n= 10 children) and Musubi (n= 9 children); and one school, Kocoge (n= 3
children), from Tororo district close to the Kenyan border (Fig. 1). These two
districts, Mayuge and Tororo, were chosen as they had undergone long- and short-
term MDA pressure, respectively (Table 1). For all sites, ~6 months had elapsed
between the prior round of MDA and the pre-treatment sample collection for this
study. Miracidia were isolated from infected children 1–3 days prior to treatment
with praziquantel (40 mg/kg) for schistosomiasis, and albendazole (400 mg) for
soil-transmitted helminths, and again in cases of incomplete clearance 25–27 days
following treatment. The follow-up time frame was short to identify only treatment
failures and reduce the probability of observing eggs from prepatent infections108.
Stool samples were washed and filtered to retain parasite eggs with a
Pitchford–Visser funnel. The filtrate was stored overnight in a petri-dish and
hatched the next morning in sunlight. Miracidia were transferred in 3 μl of water
into two sequential dishes of nuclease-free water to dilute bacterial contaminants
and subsequently spotted, individually, onto Whatman FTA® cards.
Egg reduction rate (ERR) calculations for individuals and groups were
estimated based on three days of duplicate pre- and post-treatment Kato-Katz
slides using a mixed-effects regression model (https://github.com/jacotton/
ERR_mixed_model)42. These scripts fit a Poisson generalized linear model to
previously published pre- and post-sampling egg count data109 with potential
confounders included as main effects and school-level nested random effects using
MCMCglmm (v.2.32)110.
Parasite material was purposively selected following sample collection to
represent a broad range of clearance phenotypes at the host level (Supplementary
Data 9). Individuals were defined as having a ‘good clearance’ phenotype if no
miracidia could be isolated from stool samples after treatment, or a ‘poor clearance’
phenotype if miracidia could be isolated following treatment. For poor-clearing
individuals, it was therefore possible to obtain miracidia both before and after
anthelmintic treatment. The posterior mean ERR for good clearing individuals
ranged from 99.4 to 99.9% (median= 99.92%, 95% credible interval for median
99.85–99.98%) and for poor-clearing individuals from 24.2 to 99.4%
(median= 90.93%, 95% credible interval for median 86.16–95.22%), calculated
using the same model as in Crellen et al.42 but including only those individuals for
which miracidia were sequenced.
From 34 infected children, we aimed to sequence five randomly selected
miracidia per child before treatment and, in the case of poor-clearing individuals,
five randomly selected miracidia after treatment. In practice, there was not always
sufficient parasite material, particularly from post-treatment egg collections, and so
the number of miracidia at each timepoint varied from 1 to 9 (Fig. 1,
Supplementary Data 9). In total we selected 222 miracidia, of which 204 were from
31 children in schools in Mayuge district (Bugoto n= 86, Bwondha, n= 67,
Musubi n= 51) and 18 were from 3 children Kocoge school, in Tororo district.
Overall 165 miracidia were sampled before treatment with praziquantel and 57
miracidia were sampled after treatment.
DNA sequencing. All sequenced samples were archived in the Schistosome Col-
lection at the Natural History Museum (SCAN) prior to extraction111. Each mir-
acidium was isolated from Whatman FTA® cards using a Harris 2 mm micro-
punch and placed into 1.5 ml microcentrifuge tubes. DNA was extracted using a
Qiagen DNeasy Blood and Tissue Extraction Kit following the manufacturer’s
instructions with the following alterations. 45 μl ATL buffer and 5 μl proteinase K
were added to each tube and tubes were then vortexed, followed by incubation
(56 °C on a rocking platform for 1 h). We added 50 μl of buffer AL and vortexed,
then added 50 μl of 100% ethanol and the tubes were vortexed again. We removed
150 μl of liquid and pipetted it onto a spin column inside a collection tube. After
centrifugation (6000 × g, 1 min), the collection tube was replaced and 500 μl of
buffer AW1 was added to each spin column. After centrifugation (6000 × g, 1 min),
the collection tube was replaced and 500 μl buffer AW2 was added to each spin
column. After centrifugation (20,000 × g, 3 min), the collection tube was discarded
and replaced with a 1.5 ml microcentrifuge tube. Fifty microliters of buffer AE
(37 °C) was added to the spin column membrane and centrifuged (6000 × g, 1 min),
an additional 50 μl of buffer AE (37 °C) was then added to the spin column
membrane and centrifuged (6000 × g, 1 min).
DNA eluate was concentrated down to 10–50 μl using Savant SpeedVac (30 °C).
Ten microliters of 2x denaturation buffer (GenomiPhi V3 amplification kit) was
added and the tubes were heated (95 °C, 3 min) and cooled to 4 °C on ice.
Denatured DNA was then added to the GenomiPhi freeze-dried pellet and
incubated (30 °C, 90 min), before being cooled to 4 °C on ice. Amplified DNA was
purified with magnetic AMPure XP beads and eluted in 50 μl nuclease-free water.
Library preparation was performed by Wellcome Sanger Institute core facilities
using NEBNext Ultra kit (New England Biolabs, E7370S) and KAPA HiFi HS
ReadyMix (Kapa Biosystems, cat. no. KK2603) and either 8 or 18 PCR cycles were
performed depending on library concentration Libraries were multiplexed and
150 bp paired-end reads were generated with the Illumina HiSeq X10 platform.
Raw sequencing data generated during this study are available in the European
Nucleotide Archive (ENA) repository under study accession number ERP113930
(Supplementary Data 2).
SNP discovery and annotation. The S. mansoni reference genome (v.7) was
downloaded from WormBase Parasite112,113 and scaffolds labelled as haplotype
variants were removed using seqtk (https://github.com/lh3/seqtk; Supplementary
Data 11). All sample reads were screened with Kraken (v.0.10.6) against a database
of five standard datasets (Human, Mouse, Bacteria, Virus and Plasmid; Supple-
mentary Data 12)114. Sequence reads were aligned using BWA mem (v.0.7.17) and
duplicates were marked using PicardTools MarkDuplicates (as part of GATK
v.4.1.0.0)115,116. Variant calling was performed per-sample using GATK Haploty-
peCaller (v.4.1.0.0) in gVCF mode. Samples were then consolidated using GATK
CombineGVCFs before joint-call cohort genotyping using GATK Genoty-
peGVCFs. GATK SelectVariants was used to separate single-nucleotide poly-
morphisms (SNPs) from indels and mixed sites before filtering using GATK
VariantFiltration. SNPs were retained if they met the following criteria: QD ≥ 2.0,
FS ≤ 60.0, MQ ≥ 40.0, MQRankSum ≥−12.5, ReadPosRankSum ≥−8.0, SOR ≤ 3.0
(Supplementary Fig. 2). Using VCFtools (v.0.1.15) we excluded samples with a high
rate of SNP missingness (>55% of sites with a missing genotype), removed sites
where >10% of samples had a missing genotype call, and finally removed all sites
with a minor allele frequency (MAF) <1% (Supplementary Fig. 2, Supplementary
Data 13)117. Variants found on the mitochondrial genome, unplaced contigs and
W chromosome scaffolds were also excluded using VCFtools (Supplementary
Data 11), leaving only variants found on the 8 chromosomal sequences (1–7 & Z)
representing 98.56% of the assembly. Variant sites containing indels or mixed sites
(variant sites that had both SNPs and indels called) were filtered independently and
variants were retained if they met the following criteria: QD ≥ 2.0, FS ≤ 200.0,
ReadPosRankSum ≥−20.0, SOR ≤ 10.0. Samples excluded during SNP filtration
were also excluded here (Supplementary Data 13). Functional annotation of SNPs
and indels was performed using snpEff (v.4.3t) with gene annotations for S.
mansoni (v.7) downloaded from WormBase Parasite.
Depth of coverage. We calculated the depth of read coverage in 2 and 25 kb windows
along each chromosome using bedtools (v.2.30.0) coverage118. To differentiate male and
female miracidia, we calculated median read coverage of the 2 kb windows across both
pseudoautosomal regions of the Z chromosome: PAR1 (coordinates 1–10,739,103 bp)
and PAR2 (coordinates 44,192,532–88,385,488 bp) and the non-recombining Z-specific
region of the Z chromosome: ZSR (coordinates 10,739,104–44,192,531 bp). Samples
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with a >0.75 ZSR/PAR ratio were designated as males and samples with <0.75 ZSR/
PAR ratio were designated females.
Sample relatedness. We used KING (v.2.1.5) to calculate kinship coefficients and
inferred identical-by-descent (IBD) segments between all pairwise combinations of
samples119. Pairwise kinship coefficient (φ) scores of >0.354, 0.177–0.354,
0.0884–0.177 and 0.0442–0.0884 were used to classify duplicate/MZ twin, 1st-
degree, 2nd-degree and 3rd-degree relationships, respectively. Relationships with
PropIBD <0.0001 were excluded.
Recombination. The decay of linkage disequilibrium with genomic distance was
determined for each population separately using VCFtools. The squared correlation
coefficient was calculated between all sites within 50 kb and filtered to remove
variants with minor allele frequency <5%. When populations had unequal numbers
the larger population was randomly subsampled into multiple non-overlapping
subpopulations equal to, or less than, the smallest population. Median values were
calculated for each distance and plotted using the geom_smooth function of
ggplot2 for each population, combining subsampled populations120.
Population genomic structure. To analyse population structure, we used PLINK
(v.2.0) to first remove variants found to be in strong linkage disequilibrium121.
Variants were discarded according to the observed correlation between pairs of
variant sites. The genome was scanned in sliding windows of 50 variants, in steps of
10 variants, and variants within windows with squared correlation coefficients
≥0.15 were removed (Supplementary Fig. 19). Variants found on the Z chromo-
some were also excluded. Principal component analysis (PCA) was performed
using the remaining 1,344,965 variants using PLINK. Admixture analysis was
performed using ADMIXTURE122 with K values (number of hypothetical ancestral
populations) ranging from 1 to 20, 10-fold cross-validation, standard error esti-
mation with 250 bootstraps and repeated the process 10 times with different
random seeds. The lowest cross-validation error (CV) value was found for K= 1
increasing for each value of K (Supplementary Fig. 5).
The 1,344,965 autosomal variants were used to construct a neighbour-joining
tree. An identity-by-state distance matrix with distances expressed as genomic
proportions was generated by PLINK. The ape (v.5.2) bionj algorithm was run on
the resulting distance matrix123. The tree was midpoint rooted using phangorn
(v.2.4.0) midpoint function and visualised using ggtree (v.1.10.5)124,125.
PIXY (v.0.95.01) was used to calculate the nucleotide diversity (π), fixation
index (FST) and absolute divergence (dXY), in 5 kb sliding, non-overlapping
windows across each autosome for each school and district population126. Negative
FST values were corrected to 0 prior calculation of genome-wide median values for
each population. Confidence intervals for these medians were calculated as the
quantiles of the distribution of medians of 1000 bootstrap samples of genomic
windows for each population.
The impact of praziquantel treatment on population genomic diversity. PIXY
was used to calculate the nucleotide diversity (π), fixation index (FST) and absolute
divergence (dXY), in 5 kb, non-overlapping windows across each autosome for each
treatment sampling stage and infrapopulation. For comparisons of infrapopula-
tions, all samples from two children were excluded from π analyses as well as FST
and dXY comparisons due to consistently low coverage across all infrapopulation
samples (Supplementary Data 2). VCFtools was used to calculate the fixation index
(FST) in 2 kb windows for each treatment sampling stage. We tested for significant
differences between male and female infrapopulations using a two-tailed t-test
comparing median autosomal nucleotide diversity for each infrapopulation.
Pearson correlation coefficients and p-values analysing the relationship between
age or infrapopulation size were calculated using the ggpubr (stat_cor) function
using default parameters127.
Detection of genome-wide signatures of selection. Statistical phasing was
performed using Beagle (v.5.0) and a recombination map based on per-
chromosome recombination rate estimates from Criscione et al.128,129. The effec-
tive population size was set at 65,000 based on estimates by Crellen et al.17.
4,428,787 phased bi-allelic variants were then used to calculate the integrated
haplotype scores (iHS) and cross-population extended haplotype homozygosity
(XP-EHH) using Selscan (v.1.2.0a) for each chromosome separately130. Normal-
isation was performed for all Selscan outputs across all chromosomes using norm
(v.1.2.0a) distributed with Selscan130. Median iHS and XP-EHH scores were cal-
culated for 2 kb non-overlapping windows along each chromosome. VCFtools was
used to calculate fixation index (FST) and π in 2 kb sliding, non-overlapping
windows across each chromosome. The ratio in nucleotide diversity was calculated
as the median π value within each 2 kb window between Mayuge and Tororo
district populations. For all four statistics windows with fewer than 20 variants per
2 kb window were removed (n= 3207). Consistent signals across multiple statistics
were taken as strong evidence of selection131. The highest 0.25% of Mayuge |iHS|,
XP-EHH and FST windows were considered candidate regions of selection. Any
windows within 300 kb of another were joined into single continuous regions of
selection, these were then manually inspected, extending regions where peak
structure was not fully encompassed. Any windows found within the Z-specific
region (located between 10.74 and 44.19 Mb) on the Z chromosome were not
included as candidate regions of selection.
As additional supporting evidence we calculated Tajima’s D statistic in 2 kb
non-overlapping windows using VCFtools. As above the same windows with fewer
than 20 variants per 2 kb were removed. In addition, per variant site FST and π
values were calculated using VCFtools (Supplementary Data 14).
Association testing. Association tests were performed following removal of variants
in close linkage as described above. In addition, variants with a minor allele frequency
<5% were then removed. Two different association tests were performed. First, a logistic
regression genome-wide association study was performed between samples from chil-
dren with ‘good clearance’ phenotypes and post-treatment samples from children with
poor clearance phenotypes (using 281,350 variants). Second, a linear regression
genome-wide association study was conducted in PLINK (v.1.9) with the ERR estimates
for all 198 samples, using the mean of the posterior ERR estimates from Crellen et al.17
as a quantitative trait (using 281,954 variants). For both tests, the first four principal
components of the PCA were used as covariates, and a Bonferroni corrected threshold
was used to determine significance.
Inference of population history. We used SMC++ (v1.15.2) to estimate the size
history of each population132. SMC++ was run on each autosome using a per-
generation mutation rate of 8.1e−9 and a generation time of 71 days17. All samples
from each population (for each school or, in the case of outgroups, each country)
were included. Subsampled replicates were produced by randomly subsampling
7.5 Mb from each chromosome 25 times for each population. One-dimensional site
frequency spectrum was calculated using easySFS (https://github.com/
isaacovercast/easySFS), we projected down to 15 samples per population and
plotted estimates produced by δaδi (v.2.7.0)133. This was repeated for a total of five
replicates. For analyses of recent demographic history, the Tajima’s D statistic was
calculated in 5 kb non-overlapping windows using VCFtools.
Software. For all software, unless otherwise stated, default parameters were used.
All figures were produced with R (3.5.1), ggplot2 (v.3.1.0) and cowplot120,134,135. A
map of sampled regions was generated with QGIS (v.3.2.2) using raster and vector
map data from Natural Earth (found at naturalearthdata.com). GNU parallel136,
GNU datamash (v1.4, gnu.org/software/datamash) and BCF tools137 were used at
multiple stages to facilitate data processing and analyses.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The sequencing data generated in this study have been deposited in the European
Nucleotide Archive (ENA) repository under accession code PRJEB31375. Individual
sample accessions are listed in Supplementary Data 10. Source data are provided as a
Source Data folder and are also available at [https://doi.org/10.5281/zenodo.4940588]138.
Genome and annotation files are available through WormBase Parasite [https://parasite.
wormbase.org/Schistosoma_mansoni_prjea36577/Info/Index/]. Egg count data used to
produce the egg reduction rate estimates are available [10.13140/RG.2.2.12687.84640]. To
reduce the number of indirect identifiers available, children’s ages removed, access can be
obtained upon reasonable request to the corresponding authors. Source data are provided
with this paper.
Code availability
The code used for data analysis is available at [https://doi.org/10.5281/
zenodo.4975908]139.
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